272 related articles for article (PubMed ID: 25773929)
1. Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast.
Lien HC; Chen YL; Juang YL; Jeng YM
Breast Cancer Res Treat; 2015 Apr; 150(2):447-55. PubMed ID: 25773929
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Shamir ER; Chen YY; Krings G
Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Coexisting Lobular Carcinoma In Situ With Invasive Lobular Carcinoma.
Harbhajanka A; Lamzabi I; Syed S; Jain R; Ghai R; Reddy VB; Bitterman P; Gattuso P
Appl Immunohistochem Mol Morphol; 2016; 24(10):738-743. PubMed ID: 26574630
[TBL] [Abstract][Full Text] [Related]
5. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
[TBL] [Abstract][Full Text] [Related]
6. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
7. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
Ross JS; Wang K; Sheehan CE; Boguniewicz AB; Otto G; Downing SR; Sun J; He J; Curran JA; Ali S; Yelensky R; Lipson D; Palmer G; Miller VA; Stephens PJ
Clin Cancer Res; 2013 May; 19(10):2668-76. PubMed ID: 23575477
[TBL] [Abstract][Full Text] [Related]
8. HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features.
Ding Q; Chen H; Lim B; Damodaran S; Chen W; Tripathy D; Piha-Paul S; Luthra R; Meric-Bernstam F; Sahin AA
Hum Pathol; 2019 Oct; 92():32-38. PubMed ID: 31351155
[TBL] [Abstract][Full Text] [Related]
9. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
Kurozumi S; Alsaleem M; Monteiro CJ; Bhardwaj K; Joosten SEP; Fujii T; Shirabe K; Green AR; Ellis IO; Rakha EA; Mongan NP; Heery DM; Zwart W; Oesterreich S; Johnston SJ
Breast Cancer Res; 2020 Aug; 22(1):85. PubMed ID: 32782013
[TBL] [Abstract][Full Text] [Related]
10. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.
Hwang ES; Nyante SJ; Yi Chen Y; Moore D; DeVries S; Korkola JE; Esserman LJ; Waldman FM
Cancer; 2004 Jun; 100(12):2562-72. PubMed ID: 15197797
[TBL] [Abstract][Full Text] [Related]
11. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
[TBL] [Abstract][Full Text] [Related]
12. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
[TBL] [Abstract][Full Text] [Related]
13. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
14. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
[TBL] [Abstract][Full Text] [Related]
15. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
16. Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics.
Yu J; Dabbs DJ; Shuai Y; Niemeier LA; Bhargava R
Am J Clin Pathol; 2011 Jul; 136(1):88-97. PubMed ID: 21685036
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
Andrade VP; Morrogh M; Qin LX; Olvera N; Giri D; Muhsen S; Sakr RA; Schizas M; Ng CK; Arroyo CD; Brogi E; Viale A; Morrow M; Reis-Filho JS; King TA
Mol Oncol; 2015 Apr; 9(4):772-82. PubMed ID: 25601220
[TBL] [Abstract][Full Text] [Related]
19. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
[TBL] [Abstract][Full Text] [Related]
20. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
